NCT06234384 Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
| NCT ID | NCT06234384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation for Sarcoidosis Research |
| Condition | Sarcoidosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,833 participants |
| Start Date | 2013-07 |
| Primary Completion | 2033-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,833 participants in total. It began in 2013-07 with a primary completion date of 2033-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of sarcoidosis, support research, and better understand the needs of the sarcoidosis community.
Eligibility Criteria
Inclusion Criteria: 1. English speaking 2. Consent 3. Sarcoidosi diagnosis - Exclusion Criteria: NONE
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06234384 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, studying Sarcoidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06234384 currently recruiting?
Yes, NCT06234384 is actively recruiting participants. Contact the research team at info@stopsarcoidosis.org for enrollment information.
Where is the NCT06234384 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06234384 clinical trial?
NCT06234384 is sponsored by Foundation for Sarcoidosis Research. The trial plans to enroll 6,833 participants.